Rocket Pharmaceuticals said Tuesday that a patient had died in a trial studying its experimental gene therapy for a rare heart condition called Danon disease.
Rocket did not disclose the patient’s age, although the Phase 2 study aimed to enroll boys and young men. The company said it was…